Maria Koehler - 10 Dec 2021 Form 4 Insider Report for Repare Therapeutics Inc. (RPTX)

Role
EVP, Chief Medical Officer
Signature
/s/ Steve Forte, Attorney-in-Fact
Issuer symbol
RPTX
Transactions as of
10 Dec 2021
Net transactions value
+$100,048
Form type
4
Filing time
10 Dec 2021, 15:43:34 UTC
Next filing
23 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPTX Common Shares Options Exercise $99,925 +48,460 +92% $2.06* 100,955 10 Dec 2021 Direct
transaction RPTX Common Shares Options Exercise $124 +51 +0.05% $2.42* 101,006 10 Dec 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RPTX Employee Stock Option (right to buy) Options Exercise $0 -48,460 -34% $0.000000 92,875 10 Dec 2021 Common Shares 48,460 $2.06 Direct F1
transaction RPTX Employee Stock Option (right to buy) Options Exercise $0 -51 -0.05% $0.000000 111,298 10 Dec 2021 Common Shares 51 $2.42 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of the shares subject to the option vested on May 1, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.
F2 Twenty-five percent (25%) of the shares subject to the option vested on December 16, 2020, and one thirty-ninth (1/39th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.